![Paul Rennie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Rennie
Chief Executive Officer at
PARADIGM BIOPHARMACEUTICALS LIMITED
Net worth: 2 M $ as of 2026-06-29
Profile
Paul John Rennie is the founder of Paradigm Biopharmaceuticals Ltd., where he currently holds the title of Executive Chairman & Managing Director.
Paradigm Biopharmaceuticals Ltd. was founded in 2014.
In addition to his founding position, Mr. Rennie has held former positions at Neuroscientific Biopharmaceuticals Ltd. as Non-Executive Chairman, Stiefel Research Australia Pty Ltd. as Director-Business Development, Merck KGaA as National Manager-Sales Marketing, Bonlac Foods Ltd. as Manager-Business Development, Mesoblast Ltd. as Executive Vice President-New Product Development, and Roche Diagnostics Australia Pty Ltd. as Manager-Sales & Marketing.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-17 | 21,409,425 ( 3.66% ) | 2 M $ | 2026-06-29 |
Paul Rennie active positions
| Companies | Position | Start |
|---|---|---|
| PARADIGM BIOPHARMACEUTICALS LIMITED | Chief Executive Officer | 2022-11-21 |
Former positions of Paul Rennie
| Companies | Position | End |
|---|---|---|
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Chief Executive Officer | 2023-09-10 |
Stiefel Research Australia Pty Ltd.
 Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Develops delivery systems for new dermatology products | Corporate Officer/Principal | - |
| MERCK KGAA | Sales & Marketing | - |
Roche Diagnostics Australia Pty Ltd. | Sales & Marketing | - |
| MESOBLAST LIMITED | Chief Operating Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Bonlac Foods Ltd.
 Bonlac Foods Ltd. Food DistributorsDistribution Services Manufactures dairy products and ingredients | Distribution Services |
Stiefel Research Australia Pty Ltd.
Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Develops delivery systems for new dermatology products | Health Technology |
Mesoblast Ltd.
 Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Roche Diagnostics Australia Pty Ltd. | |
Paradigm Biopharmaceuticals Ltd.
 Paradigm Biopharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Engages in repurposing the drug, pentosan polysulphate sodium for the treatment of bone marrow edema | Health Technology |
Neuroscientific Biopharmaceuticals Ltd.
 Neuroscientific Biopharmaceuticals Ltd. BiotechnologyHealth Technology Engages in researching and developing pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Paul Rennie
Choose MarketScreener 
